Fingerprint
Dive into the research topics of 'Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: A post hoc analysis from ORAL Surveillance'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically